Cadrenal Therapeutics, Inc. — Form D

Cadrenal Therapeutics, Inc. of PONTE VEDRA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-31. The offering totals $4.4M, of which $4.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
LEE S GOLDENDirectorPONTE VEDRA, FL
JOHN R MURPHYDirectorPONTE VEDRA, FL
QUANG X PHAMDirectorPONTE VEDRA, FL
GLYNN J WILSONDirectorPONTE VEDRA, FL
STEVEN J ZELENKOFSKEDirectorPONTE VEDRA, FL
JEFFREY K COLEExecutive OfficerPONTE VEDRA, FL
JAMES J FERGUSONExecutive OfficerPONTE VEDRA, FL
QUANG X PHAMExecutive OfficerPONTE VEDRA, FL
Matthew K SzotExecutive OfficerFresno, CA
Jeffrey ColeRelated PersonToronto, A6
John MurphyDirectorBeaver Falls, PA
Steven W ZelenkofskeDirectorPonte Vedra, FL
Jeff W ColeExecutive OfficerPonte Vedra, FL
Glynn W WilsonDirectorPonte Vedra, FL
Matthew SzotExecutive OfficerPonte Vedra, FL
Matthew SzotRelated PersonPonte Vedra, FL
Douglas W LosordoExecutive OfficerPonte Vedra, FL
Quang PhamDirectorPonte Vedra, FL
Quang PhamExecutive OfficerPonte Vedra, FL
Robert W LisickiDirectorPonte Vedra, FL
Glynn WilsonDirectorPonte Vedra, FL
Glynn WilsonRelated PersonPonte Vedra, FL
STEVEN ZELENKOFSKEDirectorPonte Vedra, FL
STEVEN ZELENKOFSKERelated PersonPonte Vedra, FL
Douglas LosordoExecutive OfficerPONTE VEDRA, FL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-15D$8.8M$8.8M
2026-04-06D$7.9M$7.9M
2024-11-14D$9.4M$9.4M
2023-07-18D$7.5M$7.5M
2022-12-08D$1.0M$250K
2022-07-25D$2.0M$150K

More